El Segundo, CANCT06710288Now EnrollingIRB Ready

Ovarian Cancer Clinical Trial in El Segundo, CA

Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in El Segundo. Study-provided care at no cost to qualified participants.

Sponsored by ImmunityBio, Inc.

Quick Self-Assessment

See if you qualify for this El Segundo location

Preparing your pre-screening questions...

Expert Care in El Segundo

Access ovarian cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ovarian cancer treatment provided free

Apply for This El Segundo Location

Check if you qualify for this ovarian cancer clinical trial in El Segundo, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to El Segundo

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit El Segundo site if eligible
  4. 4Begin participation

About This Ovarian Cancer Study in El Segundo

This is phase 2 single arm study evaluating the safety and preliminary efficacy of M-CENK adoptive cell therapy and fixed dose of N-803 in combination with gemcitabine in participants with platinum-resistant high-grade ovarian cancer (HGOC).Up to 20 participants will receive M-CENK (IV) and N-803 (SC) in combination with gemcitabine (IV). Participants will undergo an apheresis procedure for the collection of mononuclear cells (MNCs) at least 1 day prior to Cycle 1 for manufacturing of M-CENK. S

Sponsor: ImmunityBio, Inc.

Who Can Participate

Inclusion Criteria

≥18 years and \<85 years old. 2. Able to understand and provide a signed informed consent that fulfills the relevant Institutional Review Board (IRB) or Independent Ethics Committee (IEC) guidelines. 3. Participants must be appropriate for single-agent therapy as the next line of therapy, as determined by the Investigator. 4. Participants must have received prior treatment with bevacizumab. 5. Confirmed diagnosis of platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal or fallopian tube. Platinum-resistant is defined as a relapse within 6 months of receiving 1 to 3 platinum-based chemotherapy regimens. 6. Must have at least one lesion that meets the definition of measurable disease defined by RECIST v1.1 criteria. 7. Must have received at least one but no more than three prior systemic lines of anticancer therapy and had progressive disease (PD) while receiving or immediately after receiving the previous therapy. Progression will be calcula

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in El Segundo?

Yes, this clinical trial (NCT06710288) has an active research site in El Segundo, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ovarian Cancer Treatment Options in El Segundo, CA

If you're searching for ovarian cancer treatment options in El Segundo, CA, this clinical trial (NCT06710288) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our El Segundo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ovarian cancer clinical trials near you to find additional studies recruiting in your area.

More Ovarian Cancer Trials in El Segundo, CA

See all ovarian cancer clinical trials recruiting in El Segundo — not just this study.

Browse Ovarian Cancer Trials in El Segundo →

Browse More Trials by Condition

Ovarian Cancer TrialsAll Conditions →

Ready to Join in El Segundo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · El Segundo, CA